# Device Description - NeuroPredict-AI
# FDA 510(k) Submission Document

## Document Control

| Field | Value |
|-------|-------|
| Document Title | Device Description - NeuroPredict-AI |
| Document Number | FDA-510K-DD-001 |
| Version | 1.0 |
| Date | December 2024 |
| Classification | Confidential - FDA Submission |

---

## 1. Executive Summary

NeuroPredict-AI is a Software as a Medical Device (SaMD) that provides clinical decision support for healthcare professionals in assessing the risk of Alzheimer's disease and Parkinson's disease. The device analyzes multi-modal clinical data including medical imaging (MRI), cognitive assessments, biomarkers, and genetic information to generate risk predictions and clinical recommendations.

---

## 2. Device Identification

### 2.1 Device Name
- **Primary Name**: NeuroPredict-AI
- **Trade Name**: NeuroPredict-AI Clinical Decision Support System
- **Model Number**: NPA-CDS-1.0
- **Version**: 1.0.0

### 2.2 Manufacturer Information
- **Company Name**: [نام شرکت شما]
- **Address**: [آدرس کامل]
- **Country**: [کشور]
- **Contact**: [اطلاعات تماس]

### 2.3 Device Classification
- **Regulation Number**: 21 CFR 862.1310
- **Device Class**: Class II
- **Product Code**: QDM (Computer-Assisted Diagnostic Devices for Neurological Conditions)
- **Panel**: Neurology

---

## 3. Intended Use and Indications

### 3.1 Intended Use Statement

NeuroPredict-AI is intended to:
- Provide clinical decision support to healthcare professionals for assessing the risk of Alzheimer's disease in adult patients (ages 45-85) based on clinical data, medical imaging, cognitive assessments, and biomarker information.

- Provide clinical decision support to healthcare professionals for assessing the risk of Parkinson's disease in adult patients (ages 45-85) based on clinical data, medical imaging, cognitive assessments, and biomarker information.

- Aid healthcare professionals in patient evaluation and clinical decision-making by providing risk scores, confidence levels, and evidence-based recommendations.

### 3.2 Indications for Use

The device is indicated for use:
- As an adjunct tool for healthcare professionals (physicians, neurologists) evaluating patients with:
  - Cognitive complaints or concerns
  - Early-stage cognitive impairment
  - Risk factors for neurodegenerative diseases
  - Family history of Alzheimer's or Parkinson's disease

### 3.3 Intended User Population

**Primary Users:**
- Neurologists
- Geriatricians
- Primary care physicians with neurological training
- Radiologists (for imaging review)

**Patient Population:**
- Adults aged 45-85 years
- Patients presenting with cognitive concerns
- Patients being evaluated for neurodegenerative diseases

### 3.4 Intended Use Environment

- Hospital settings (outpatient clinics, neurology departments)
- Clinical practices (neurology, geriatrics)
- Medical imaging centers
- Research institutions (for research purposes)

### 3.5 Operating Environment

**Hardware Requirements:**
- Server: 
  - CPU: 4+ cores (Intel/AMD)
  - RAM: 8GB minimum, 16GB recommended
  - Storage: 50GB available space
  - Network: Broadband internet connection

- Client:
  - Modern web browser (Chrome 90+, Firefox 88+, Safari 14+, Edge 90+)
  - Screen resolution: 1280x720 minimum
  - Internet connection: Broadband

**Software Requirements:**
- Server Operating System: Linux (Ubuntu 20.04+), Windows Server 2019+
- Database: PostgreSQL 13+ or SQLite 3.35+
- Web Server: Nginx or Apache (optional)

**Network Requirements:**
- HTTPS/TLS 1.2+ for secure data transmission
- Firewall configuration for API access
- VPN access for remote users (recommended)

---

## 4. Device Components

### 4.1 Software Components

#### 4.1.1 Backend Application
- **Technology**: FastAPI (Python 3.11+)
- **Purpose**: Core application logic, API endpoints, business rules
- **Components**:
  - Authentication and authorization system
  - Patient management module
  - Prediction engine
  - Image processing service
  - Data fusion service
  - Reporting service

#### 4.1.2 Admin Dashboard
- **Technology**: React 18, TypeScript, Vite
- **Purpose**: Administrative interface for system management
- **Components**:
  - System overview
  - User management
  - Model monitoring
  - Analytics dashboard
  - Audit logs

#### 4.1.3 AI/ML Models
- **Technology**: PyTorch 2.1+
- **Purpose**: Disease risk prediction
- **Models**:
  - Multi-modal neural network for Alzheimer's prediction
  - Multi-modal neural network for Parkinson's prediction
  - Image processing models (CNN)

#### 4.1.4 Database
- **Technology**: PostgreSQL or SQLite
- **Purpose**: Data storage and management
- **Schema**: Patient records, medical data, predictions, audit logs

#### 4.1.5 Image Processing Module
- **Technology**: PyDICOM, NiBabel, OpenCV
- **Purpose**: DICOM file processing, MRI preprocessing, feature extraction

### 4.2 Hardware Components (if applicable)

N/A - This is a software-only device.

### 4.3 Accessories (if applicable)

N/A

---

## 5. Device Operation

### 5.1 Operating Principles

NeuroPredict-AI operates through the following process:

1. **Data Input**: Healthcare professional enters patient data including:
   - Demographics (age, gender, education)
   - Cognitive test scores (MMSE, MoCA)
   - Biomarker levels (amyloid-beta, tau protein, dopamine)
   - Genetic markers (APOE ε4 status)
   - Medical imaging data (MRI scans - optional)

2. **Data Processing**:
   - Data normalization and preprocessing
   - Feature extraction from medical images (if provided)
   - Feature engineering and combination

3. **AI Analysis**:
   - Multi-modal neural network processes combined features
   - Generates risk probabilities for Alzheimer's disease
   - Generates risk probabilities for Parkinson's disease
   - Calculates confidence scores

4. **Output Generation**:
   - Risk scores (Low, Medium, High)
   - Confidence levels
   - Feature importance analysis
   - Clinical recommendations based on risk level

5. **Display and Documentation**:
   - Results displayed in user interface
   - Report generation (PDF/printable)
   - Storage in patient record

### 5.2 User Interface

- **Web-based interface**: Accessible via standard web browsers
- **Role-based access**: Different interfaces for different user roles
- **Responsive design**: Works on desktop and tablet devices
- **Accessibility**: WCAG 2.1 Level AA compliant

### 5.3 Data Flow

```
User Input → Validation → Feature Extraction → 
AI Model Processing → Risk Calculation → 
Recommendation Engine → Output Display → 
Database Storage
```

---

## 6. Device Specifications

### 6.1 Functional Specifications

| Function | Specification |
|----------|---------------|
| Multi-disease assessment | Alzheimer's and Parkinson's disease risk |
| Input modalities | Clinical data, cognitive scores, biomarkers, genetic markers, medical imaging |
| Output format | Risk scores, confidence levels, recommendations |
| Processing time | < 5 seconds per prediction |
| Concurrent users | Up to 100 concurrent users |
| Data storage | Encrypted at rest (AES-256) |
| Data transmission | Encrypted in transit (TLS 1.2+) |

### 6.2 Performance Specifications

| Metric | Specification |
|--------|---------------|
| Accuracy (Alzheimer's) | ≥ 85% (as validated in clinical studies) |
| Accuracy (Parkinson's) | ≥ 85% (as validated in clinical studies) |
| Sensitivity | ≥ 80% |
| Specificity | ≥ 85% |
| System uptime | ≥ 99.5% |
| Response time | < 3 seconds (95th percentile) |
| Data retention | Configurable (default: 10 years) |

### 6.3 Input Specifications

**Clinical Data:**
- Age: 45-85 years
- Gender: Male/Female
- Education years: 5-25 years

**Cognitive Assessments:**
- MMSE Score: 0-30
- MoCA Score: 0-30
- Memory Score: 0-100
- Attention Score: 0-100
- Executive Function Score: 0-100

**Biomarkers:**
- Amyloid-beta: 100-1000 pg/mL
- Tau protein: 50-800 pg/mL
- Dopamine level: 10-150 ng/mL

**Genetic Markers:**
- APOE ε4 status: 0 (negative) or 1 (positive)

**Medical Imaging:**
- Format: DICOM (MRI scans)
- Modalities: T1-weighted, T2-weighted, FLAIR
- Size: Standard MRI volumes

### 6.4 Output Specifications

**Risk Scores:**
- Low Risk: 0-30% probability
- Medium Risk: 31-70% probability
- High Risk: 71-100% probability

**Confidence Levels:**
- High Confidence: ≥ 80%
- Medium Confidence: 50-79%
- Low Confidence: < 50%

**Recommendations:**
- Evidence-based clinical guidance
- Follow-up testing suggestions
- Monitoring recommendations

---

## 7. Device Comparison

### 7.1 Similar Devices

NeuroPredict-AI is similar to existing computer-assisted diagnostic devices for neurological conditions that:
- Analyze clinical and imaging data
- Provide risk assessment for neurodegenerative diseases
- Support clinical decision-making

### 7.2 Key Differentiators

1. **Multi-modal approach**: Combines multiple data types (imaging, clinical, biomarkers, genetic)
2. **Multi-disease capability**: Simultaneous assessment for Alzheimer's and Parkinson's
3. **Explainable AI**: Provides feature importance and transparency
4. **Evidence-based recommendations**: Automated clinical guidance

---

## 8. Software Life Cycle

### 8.1 Software Classification (IEC 62304)

- **Classification**: Class C
- **Rationale**: 
  - Software can cause injury or death
  - Used for diagnosis and treatment decisions
  - Failure could result in incorrect diagnosis

### 8.2 Software Version Control

- Version numbering: Semantic versioning (Major.Minor.Patch)
- Current version: 1.0.0
- Change control: Documented per 21 CFR 820.30

### 8.3 Software Development Standards

- IEC 62304: Software Life Cycle Processes
- IEC 82304-1: Health Software Safety
- ISO 14971: Risk Management
- 21 CFR Part 11: Electronic Records

---

## 9. Safety and Performance

### 9.1 Safety Features

- Access control and authentication
- Audit trails for all actions
- Data encryption (at rest and in transit)
- Input validation and error handling
- Automatic backup and recovery
- Session timeout
- Role-based permissions

### 9.2 Performance Validation

- Clinical validation studies conducted
- Performance metrics validated against clinical endpoints
- Accuracy, sensitivity, specificity documented
- Validation report available

---

## 10. Labeling and Instructions

### 10.1 Device Labeling

- Device name and version
- Manufacturer information
- Intended use statement
- Indications and contraindications
- Warnings and precautions

### 10.2 Instructions for Use

- Installation instructions
- User guide
- Clinical workflow
- Troubleshooting guide
- Technical specifications

---

## 11. Regulatory History

### 11.1 Previous Submissions

- First submission for this device
- No previous 510(k) submissions

### 11.2 Other Regulatory Clearances

- None (initial submission)

---

## 12. Conclusion

NeuroPredict-AI is a Class II medical device software intended to provide clinical decision support for healthcare professionals in assessing the risk of Alzheimer's and Parkinson's diseases. The device incorporates advanced AI/ML technologies with rigorous clinical validation and safety measures.

---

## Appendices

### Appendix A: System Architecture Diagrams
See: `docs/FDA_510K_Software_Architecture.md`

### Appendix B: Performance Test Results
See: `docs/FDA_510K_Technical_Performance.md`

### Appendix C: Clinical Validation
See: `docs/FDA_510K_Clinical_Report.md`

---

**Document Prepared By**: [نام]  
**Date**: [تاریخ]  
**Approved By**: [نام]  
**Date**: [تاریخ]

---

*This document is part of the FDA 510(k) submission package for NeuroPredict-AI.*

